These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 6084321

  • 21. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J, Christe M, Lämmle B, Marbet GA, Berger W, Duckert F.
    Thromb Haemost; 1984 Dec 29; 52(3):236-9. PubMed ID: 6241750
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
    Cucuianu M, Fekete T, Marcusiu C, Mösler R, Duţu A.
    Med Interne; 1984 Dec 29; 22(3):171-7. PubMed ID: 6494764
    [Abstract] [Full Text] [Related]

  • 24. The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP.
    vd Knaap JH, de Boer AC, Pannebakker MA, van Heerde W, den Ottolander GJ.
    Thromb Haemost; 1985 Feb 18; 53(1):118-21. PubMed ID: 3922075
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
    Małyszko J, Małyszko JS, Hryszko T, Myśliwiec M.
    Thromb Haemost; 2004 Mar 18; 91(3):480-6. PubMed ID: 14983223
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 18; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 29. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C, Barton MH, Prasse KW, Moore JN.
    J Am Vet Med Assoc; 1995 Aug 15; 207(4):465-70. PubMed ID: 7591947
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Fuller JH.
    Ann Clin Res; 1984 Aug 15; 16(3):137-41. PubMed ID: 6236737
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The fibrinolysis system in diabetic glomerulosclerosis].
    Lapchinskaia II.
    Vrach Delo; 1991 May 15; (5):68-70. PubMed ID: 1866922
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Fibrinolysis and diabetic retinopathy.
    Almér LA, Pandolfi M.
    Diabetes; 1976 May 15; 25(2 SUPPL):807-10. PubMed ID: 61139
    [Abstract] [Full Text] [Related]

  • 37. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
    Melosi A, Ricci F.
    Quad Sclavo Diagn; 1983 Mar 15; 19(1):113-20. PubMed ID: 6675040
    [Abstract] [Full Text] [Related]

  • 38. Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy.
    Elder GE, Mayne EE, Daly JG, Kennedy AL, Hadden DR, Montgomery DA, Weaver JA.
    Haemostasis; 1980 Mar 15; 9(5):288-96. PubMed ID: 6157610
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Short-term and long-term intra-individual variations and critical differences of coagulation parameters.
    Costongs GM, Bas BM, Janson PC, Hermans J, Brombacher PJ, van Wersch JW.
    J Clin Chem Clin Biochem; 1985 Jul 15; 23(7):405-10. PubMed ID: 4045388
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.